The burden and costs of chronic diseases in low-income and middle-income countries DO Abegunde, CD Mathers, T Adam, M Ortegon, K Strong The Lancet 370 (9603), 1929-1938, 2007 | 2238 | 2007 |
Cost-Effectiveness of Prevention and Treatment of the Diabetic Foot A Markov analysis MM Ortegon, WK Redekop, LW Niessen Diabetes Care 27 (4), 901-907, 2004 | 277 | 2004 |
Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk … AAWA van der Heijden, MM Ortegon, LW Niessen, G Nijpels, JM Dekker Diabetes care 32 (11), 2094-2098, 2009 | 135 | 2009 |
Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study M Ortegón, S Lim, D Chisholm, S Mendis Bmj 344, 2012 | 125 | 2012 |
Iatrogenic Mycobacterium abscessus infection: histopathology of 71 patients G Rodriguez, M Ortegon, D Camargo, LC Orozco British Journal of Dermatology 137 (2), 214-218, 1997 | 119 | 1997 |
Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study AE Stanciole, M Ortegón, D Chisholm, JA Lauer Bmj 344, 2012 | 49 | 2012 |
What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia D Chisholm, R Baltussen, DB Evans, G Ginsberg, JA Lauer, S Lim, ... Bmj 344 (online), e586-e586, 2012 | 36 | 2012 |
Mental health of internally displaced preschool children: a cross-sectional study conducted in Bogotá, Colombia IJE Flink, MH Restrepo, DP Blanco, MM Ortegon, CL Enriquez, ... Social psychiatry and psychiatric epidemiology 48 (6), 917-926, 2013 | 30 | 2013 |
Mycobacterium chelonae y Mycobacterium abscessus: patógenos emergentes MM Ortegón, G Rodríguez, D Camargo, LC Orozco Biomédica (Bogotá) 16 (2), 217-38, 1996 | 18 | 1996 |
Evaluating policies to reduce teenage childbearing in Bogotá, Colombia: the effect of policies reducing costs of education faced by households1 D Cortés, J Gallego, C Latorre, D Maldonado, M Ortegón, L Pineros | 13 | 2010 |
comités de ética de la investigación en Colombia (2001-2002) MG Alterio, R Alvarado, E Cifuentes, FG Díaz, M Ortegón Revista Latinoamericana de, 2008 | 13* | 2008 |
Primera Encuesta Nacional sobre la Estructura, Organización y Funcionamiento de los Comités de Ética en Investigación en Colombia M Ortegón, R Alvarado, MG Alterio, F Garzón Avanzar Forum 3, 2002 | 6 | 2002 |
Cost effectiveness of strategies to combat chronic respiratory diseases in sub-Saharan Africa and South East Asia: mathematical modelling study A Stanciole, M Ortegon, D Chisholm, J Lauer BMJ 344, 608, 2012 | 4 | 2012 |
STRUCTURE AND ORGANIZATION OF RESEARCH ETHICAL COMMITTEES IN COLOMBIA (2001-2002) MG Alterio, R Alvarado, E Cifuentes, F Garzón Díaz, M Ortegón Revista Latinoamericana de Bioética 8 (1), 96-115, 2008 | | 2008 |
Does the FTA Have Negative Impact on the Drug Prices and the Colombians Health? An Analysis Report of Two Studies on the Impact of FTA on the Prices of Drugs in Colombia … RA Castano, D Bardey, H Jaramillo Salazar, M Ortegón, AI Vecino-Ortiz An Analysis Report of Two Studies on the Impact of FTA on the Prices of …, 2007 | | 2007 |
The burden and costs of chronic diseases in low-income and middle-income countries. Commentary R HORTON, DO ABEGUNDE, CD MOTHERS, T ADAM, M ORTEGON, ... Lancet 370 (9603), 2007 | | 2007 |
¿ Tiene efectos negativos el TLC sobre los precios de los medicamentos y la salud de los colombianos? RA Castaño, D Bardey, H Jaramillo, M Ortegón, A Vecino Borradores de Investigación: Serie documentos economia, ISSN 0124-4396, No …, 2007 | | 2007 |